BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Boehringer Ingelheim
US Army
Queensland Health
Argus Health
AstraZeneca
Johnson and Johnson
US Department of Justice
Chinese Patent Office

Generated: January 17, 2018

DrugPatentWatch Database Preview

Actavis Labs Ut Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS UT INC, and what generic and branded alternatives to ACTAVIS LABS UT INC drugs are available?

ACTAVIS LABS UT INC has twenty approved drugs.

There is one tentative approval on ACTAVIS LABS UT INC drugs.

Summary for Actavis Labs Ut Inc
US Patents:0
Tradenames:21
Ingredients:14
NDAs:20

Drugs and US Patents for Actavis Labs Ut Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc TESTOSTERONE testosterone GEL, METERED;TRANSDERMAL 204571-001 Aug 5, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LIDOCAINE lidocaine PATCH;TOPICAL 200675-001 Aug 23, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate TABLET;ORAL 017525-008 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc FIORICET W/ CODEINE acetaminophen; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 020232-001 Jul 30, 1992 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc FENTANYL-75 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-003 Aug 20, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc FENTANYL-50 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-002 Aug 20, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc CLONIDINE clonidine FILM, EXTENDED RELEASE;TRANSDERMAL 090873-002 May 6, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 076709-004 Aug 20, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate TABLET;ORAL 017525-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Actavis Labs Ut Inc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Actavis Labs Ut Inc LOXITANE C loxapine hydrochloride CONCENTRATE;ORAL 017658-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE C loxapine hydrochloride CONCENTRATE;ORAL 017658-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-004 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE loxapine succinate CAPSULE;ORAL 017525-003 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc EMLA lidocaine; prilocaine CREAM;TOPICAL 019941-001 Dec 30, 1992 ➤ Subscribe ➤ Subscribe
Actavis Labs Ut Inc LOXITANE IM loxapine hydrochloride INJECTABLE;INJECTION 018039-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Fish and Richardson
Cipla
US Army
US Department of Justice
Deloitte
Novartis
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot